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Chapter One

Literature Review

Liver Function and Structure
The function and structure of the liver are well understood. The following information on
the function and structure of the liver is adapted from Casarett and Doull’s Toxicology: The Basic Science
of Poisons (Klaassen, 2008), and Wheater’s Functional Histology: A Text and Colour Atlas (Young, 2006).

Liver Function: The liver resides within the upper abdominal quadrant between the intestinal tract
and the rest of the body. It is responsible for numerous functions including metabolism, synthesis
and secretion of bile and cholesterol, synthesis of plasma proteins, and detoxification and excretion
into bile of endogenous waste products and xenobiotics. The liver is one of the first organs to come
into direct contact with orally ingested nutrients, xenobiotics, and toxicants via blood entering the
organ through the portal vein from the intestine, and is therefore, critically important in xenobiotic
transformation, converting hydrophobic substances into water-soluble derivatives that can be
excreted into bile and urine.

Liver Structure: The liver represents approximately 2.5% of total body weight and contains various
cell types including hepatocytes (parenchymal cells), sinusoidal lining cells (Kupffer, Ito, endothelial),
hematopoietic cells, nerve cells, lymphatic cells, and blood vessel cells.
Hepatocytes represent 60-80% of the entire cell population within the liver. These cells are
large polyhedral cells with round nuclei with peripherally dispersed chromatin. The nuclei can vary
greatly in size and binucleated hepatocytes are common in normal liver.
1

Endothelial lining cells are readily distinguishable from hepatocytes by their flattened
condensed nuclei. These cells lack a basement membrane and allow for the exchange of fluids and
nutrients between hepatocytes and the sinusoid. Kupffer cells are resident macrophages of the liver
that phagocytize particles, secrete mediators of inflammation, detoxify endotoxins, process antigens,
and catabolize lipids and glycoproteins. Finally, Ito cells are fat-storing cells that serve as a major
storage site for vitamin A.
The hepatic lobule is the structural unit of the liver, defined according to structural and
functional differences. The hepatic lobule is hexagonal in shape and is centered on a terminal
hepatic venule or centrilobular venule. Portal tracts (triads) are positioned at the angles of the
hexagon. The portal triads contain branches for the portal vein, hepatic arteriole, and bile duct.
Blood flows away from the branches of the portal vein and hepatic arteriole toward the adjacent
central veins.
The hepatic lobule is divided into three zones. Zone 1 is the periportal zone. This zone is
closest to the portal tract and because hepatocytes in this zone are closest to afferent vessels, this
zone receives the most oxygenated blood.

Zone 2 is the midzonal region.

Zone 3 is the

centrilobular zone and has low levels of oxygenated blood. Gradients of proteins involved in
bioactivation, detoxification, and transportation of xenobiotics have been observed along these three
zones. For example, levels of glutathione (GSH), fatty acid oxidation, and gluconeogenesis are
highest in zone 1, but cytochrome P450, essential for drug metabolism, enzyme levels are highest
around the centrilobular venule.

Nrf2 Signaling Pathway
Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that positively
regulates the expression and activity of cytoprotective genes during periods of oxidative stress. Nrf2
2

was originally identified during a screening process for proteins that bind to the locus control region
(LCR) of the β-globin gene cluster (Moi, 1994). The β-globin gene cluster consists of five genes on
chromosome 11 which are responsible for the creation of the beta components of hemoglobin.
Within the LCR, there are four DNAse I hypersensitive sites that serve as binding sites for the
transcription factors AP1 (activation protein 1), GATA-1 (an erythroid specific transcription factor),
and NF-E2 (nuclear factor erythroid 2). It was during this screening process that a binding protein,
given the name Nrf2, was identified and was shown to exhibit remarkable similarity to NF-E2.
Nrf2 was found to bind the same hypersensitive sites as NF-E2 within the LCR of the βglobin gene cluster. Furthermore, both are RNA polymerase activators and belong to the cap ‘n’
collar family of transcription factors, members of which share a conserved basic leucine zipper
structure (Moi, 1994). However, unlike NF-E2 which is predominately expressed in erythroid cells,
Nrf2 was found to be ubiquitously expressed in all cell types, most predominantly in the kidney,
muscle, lung, heart, liver, and brain (Andrews, 1993, Chan, 1996, Itoh, 1995, McMahon. 2001, Moi,
1994).

Negative Regulation of Nrf2
Under basal conditions, Kelch-like ECH-associated protein 1 (Keap1) is a negative regulator
of Nrf2, responsible for the binding and inactivation of Nrf2 in the cytoplasm (Itoh, 1999, Kang,
2004). The double glycine repeat (DGR) region of Keap1 binds the Nrf2-ECH homology 2 (Neh2)
domain in the N-terminus region of Nrf2, thereby sequestering Nrf2 in the cytosol and repressing
its activity (Itoh, 1999). The BTB (broad complex, tramtrack, bric-a-brac) domain of Keap1 binds
Cullin-3 of the Cullin3/Ring Box 1 (Cul3/Rbx1) E3 ubiquitin ligase complex which is responsible
for the recruitment of ubiquitin-conjugating enzymes that in turn, label Nrf2 for proteosomal
degradation.

Consequently, under normal cellular conditions, the cytosolic Keap1/Cul3-Rbx1
3

complex is constantly degrading Nrf2.

However, in the presence of oxidative stress, Nrf2

dissociates from Keap1 and translocates into the nucleus of the cell leading to the activation of
antioxidant response element (ARE)-mediated gene transcription.
A number of plausible mechanisms for the dissociation of Nrf2 from Keap1 have been
suggested. Phosphorylation of a serine residue at position 40 on Nrf2 in response to electrophilic or
oxidative stress has been shown to result in the release of Nrf2 from Keap1 (Bloom, 2003). There
are also three cysteine residues on Keap1 crucial for its activity including Cys151, Cys273, and
Cys288. Research has shown that modification of Cys151 leads to a change in the conformation of
the BTB domain of Keap1, causing a switch of ubiquitination of Nrf2 to Keap1, which is thought to
lead to Nrf2 nuclear accumulation (Zhang, 2003). Mutations of a serine residue at position 104 on
Keap1 have also been shown to disrupt Keap1 dimerization, leading to the release of Nrf2 (Zipper,
2002). Furthermore, de-phosphorylation of a tyrosine residue at position 141 on Keap1 causes
destabilization and degradation of the cytosolic protein leading to the release of Nrf2 (Jain, 2008). It
remains uncertain, however, whether the above mechanisms work in concert with one another or
are independent in their ability to cause the dissociation of Nrf2 from Keap1.

Nrf2-Mediated Transcription
Once inside the nucleus, Nrf2 heterodimerizes with transcriptional regulatory proteins such
as Maf or Jun proteins (Aleksunes, 2007). These Nrf2 partners are often members of the activator
protein-1 (AP-1) family of proteins (Itoh, 1997, Wild, 1999). These heterodimeric complexes are
then able to bind ARE sequences in the promoter regions of genes involved in cytoprotection. The
functional ARE sequence contains a common core 5’-GTGACnnnGC-3’ motif, where ‘n’ represents
any nucleotide (Rushmore, 1991). Jun, for example, has been shown to interact with Nrf2 and

4

overexpression of both Jun and Nrf2 in hepatoma cells activates ARE-mediated transcription
(Venugopal, 1998).

Nrf2-Responsive Genes
ARE-containing genes identified as targets of Nrf2 are involved in a variety of cellular
functions including xenobiotic metabolism, reactive oxygen species scavenging, GSH homeostatsis,
and xenobiotic efflux transport pathways (Nguyen, 2003). These genes include, among others,
NAD(P)H quinone oxidoreductase 1 (Nqo1), heme oxygenase 1 (Ho-1), multidrug resistanceassociated protein transporters (Mrp1-4), glutamate cysteine ligase catalytic subunit (Gclc), and
glutamate cysteine ligase modifier subunit (Gclm) (Aleksunes, 2007). An impaired expression of
these genes can increase the sensitivity of cells to oxidative damage.
NAD(P)H Quinone Oxidoreductase 1: NAD(P)H quinone oxidoreductase 1 (Nqo1) is a detoxification
enzyme that reduces reactive quinones and quinone-imines to less reactive and less toxic
hydroquinones (Siegel, 2004). Early studies identified an ARE sequence in the mouse and rat Nqo1
promoter region (Rushmore, 1991).

Additionally, chemical treatment with the Nrf2 activator

butylated hydroxyanisole (BHA) increases hepatic and intestinal Nqo1 expression levels in wild-type,
but not Nrf2-null, mice (Ishii, 2002), confirming a regulatory role for Nrf2 in the expression of
Nqo1.
Heme Oxygenase-1: Heme oxygenase-1 (Ho-1) catabolizes prooxidant heme to carbon monoxide,
biliverdin, and free iron. Its name is synonymous with heat shock protein 32. Ho-1 is a hallmark
target of Nrf2 (Alam, 1999) and is commonly up-regulated following oxidative stress and cellular
injury (Guo, 2001). Unlike Nqo1, traditionally considered a drug metabolizing enzyme, Ho-1 is
more often thought of as a stress-inducible gene.
5

Multidrug Resistance-Associated Protein Transporters: In addition to the detoxification of chemicals as a
means for ameliorating cellular injury, plasma membrane efflux transport proteins can eliminate
chemicals from within the cell, thereby minimizing cellular stress and injury. Literature suggests that
ATP-dependent efflux transporters including multidrug resistance-associated proteins (Mrps) may
be involved in the antioxidant response (Klaassen, 2005). Mrps belong to the ATP-binding cassette,
subfamily c (Abcc). ARE sequences have been identified in the mouse Mrp1 (Hayashi, 2003) and
Mrp2 (Vollrath, 2006) promoters. Furthermore, treatment of mice with Nrf2 activating chemicals
shows induction of Mrps in wild-type mice (Maher, 2005, Aleksunes, 2008), but not in Nrf2-null
mice (Aleksunes, 2008), confirming the role of these transporter proteins in the Nrf2 response
pathway.
Glutamate Cysteine Ligase:

Glutamate cysteine ligase (Gcl), also known as γ-glutamyl cysteine

synthetase, catalyzes the formation of γ-glutamylcysteine, the rate-limiting step in GSH synthesis,
from glutamine and cysteine in the presence of ATP. Glutathione (GSH) plays an important role in
intracellular redox balance and protecting against cellular oxidative stress through the detoxification
of chemicals by directly binding or enzymatic conjugation. Gcl is comprised of a catalytic (Gclc)
subunit and modifier (Gclm) subunit, both of which contain ARE sequences in their promoter
regions (Seelig, 1984, Mulcahy, 1997). The catalytic subunit composes the heavy chain portion of
Gcl while the modifier subunit is known to increase the efficiency of the catalytic subunit. Livers
from Nrf2-null mice show diminished gene expression of both Gclc and Gclm as well as lower GSH
stores when compared to wild-type counterparts (Chan, 2000, Chanas, 2002). The regulation of
Gclc and Gclm by Nrf2 highlights the critical role this nuclear transcription factor undertakes in
maintaining cellular GSH homeostasis.

6

Acetaminophen (APAP) Hepatotoxicity
Incidence: Acetaminophen (APAP) is a commonly used analgesic and antipyretic. APAP is also one
of the leading causes of acute liver failure (ALF) in the United States (Reuben, 2010). Since the early
2000’s, APAP has been attributed to approximately 50% of all acute liver failure cases across the
United States (Reuben, 2010). To address this concern, in January 2011, the United States Food and
Drug Administration recommended to manufacturers of prescription combination drug products
containing acetaminophen to limit the amount of acetaminophen to no more than 325 milligrams
per tablet or capsule (U.S. Food and Drug Administration, 2011).
Currently, N-Acetyl cysteine (NAC), a precursor to GSH, is the only standard therapy used
to prevent and decrease APAP-induced hepatotoxicity. However, this treatment is administered
only in a hospital setting and must be administered within 8 hours following overdose to be most
effective (Algren, 2008). In the case of accidental overdose, however, ALF may not be evident
within 8 hours, at which point administration of NAC is no longer beneficial (Larson, 2005). It is
clear from these data that APAP hepatotoxicity is a significant human health problem.

Metabolism:

At therapeutic doses, the majority of APAP is metabolized in the liver by

glucuronidation and sulfation to APAP-GLU and APAP-SUL conjugates, respectively (Heard,
2008). Only a small portion of APAP, approximately 5%, is metabolized in the liver by cytochrome
P450 enzymes, Cyp1a2, Cyp3a11, and Cyp2e1, to a toxic reactive metabolite N-acetyl-pbenzoquinone imine (NAPQI) (Dahlin, 1984) which is efficiently inactivated by hepatic GSH pools
(Chen, 2003).

At toxic doses, however, the glucuronidation and sulfation pathways become

saturated and an excess amount of NAPQI is formed leading to a rapid depletion of hepatic GSH.
NAPQI, in turn, covalently binds to cellular macromolecules resulting in the production of reactive
oxygen species and leading to oxidative stress and hepatocellular damage (Jaeschke, 2006).
7

Nrf2 and APAP Hepatotoxicity: APAP leads to the nuclear accumulation of Nrf2 in mouse liver
(Goldring, 2004). Various studies have shown increased expression of downstream Nrf2 target
genes in mouse liver following APAP administration including Nqo1, Ho-1, and Gclc (Goldring,
2004, Aleksunes, 2006b). Similar observations have also been observed for Nqo1 in human liver
tissue samples obtained during transplantation following APAP overdose (Aleksunes, 2006a).
Nrf2-null mice exhibit enhanced hepatocellular injury compared to their wild-type
counterparts following APAP administration (Chan, 2001, Enomoto, 2001). Reduced APAP-GLU
conjugate formation was hypothesized to contribute to this increased susceptibility of Nrf2-null
mice to APAP-induced hepatotoxicity. This was supported by enhanced immunohistochemical
staining of APAP-adducted proteins in Nrf2-null mouse liver sections as well as lower mRNA
expression and activity of Ugt1a6, an enzyme involved in the glucuronidation and detoxification of
APAP (Enomoto, 2001). Nrf2-null mice also exhibit lower basal expression of downstream Nrf2
target genes including Nqo1 and Gclc (Aleksunes, 2008). Furthermore, hepatic mRNA expression of
these genes is significantly induced at 24 hours following APAP administration in wild-type mice,
with a significant induction in protein seen at 48 hours, but no induction in mRNA or protein is
observed in Nrf2-null mice (Aleksunes, 2008). Nrf2 not only regulates the expression of genes
involved in the metabolism of APAP, but additionally influences the expression of cytoprotective
genes associated with alleviating APAP hepatotoxicity.

Differential Susceptibility of Males and Females to APAP Hepatotoxicity
Sex is known to play an important role in drug absorption, metabolism, distribution, and
excretion (Morris, 2003, Tanaka, 1999). Previous work has shown sex differences in susceptibility to
APAP hepatotoxicity in mice, however, the mechanism(s) underlying these sex differences remains
unknown. Interestingly, in CD-1 mice, one study reported no sex differences with respect to
8

APAP-induced hepatotoxicity (Hoivik, 1995), however, a more recent study suggests that female
CD-1 mice are more resistant to APAP-induced hepatotoxicity than their male counterparts
(Masubuchi, 2011). This latter study observed elevated alanine aminotransferase (ALT) activity in
male CD-1 mice but not in female CD-1 mice following APAP administration. Furthermore,
histological examination of liver tissue sections at 24 hours following APAP administration revealed
hemorrhage and centrilobular necrosis only in the male CD-1 mice. The factors responsible for the
variations in the results of these studies is unknown but may be a result of differing dosing regimens.
Recent studies have also shown that male C57BL/6 mice are more susceptible to APAP
hepatotoxicity than their female counterparts (Dai, 2006, McConnachie, 2007). For these reasons,
male mouse models are more often employed in APAP-induced hepatotoxicity studies than female
mouse models.

This subsequently results in only a small amount of literature exploring the

differential susceptibility of male and female mice to APAP-induced hepatotoxicity.
A recent study has also suggested that acetaminophen metabolism does not contribute to sex
differences in its hepatotoxic effect in mice (Dai, 2006). It is known that APAP is metabolized by
Cyp1a2, Cyp3a11, and Cyp2e1 to the toxic reactive metabolite NAPQI. This 2006 study reported
observing significantly lower basal level mRNA expression of Cyp1a2 in livers of female than male
mice (Dai, 2006). However, further analysis showed no significant sex differences in NAPQI
covalent binding, suggesting that bioactivation of APAP is similar between sexes.
In humans, the differential susceptibility of males and females to APAP hepatotoxicity is less
clear. A higher female predominance of acetaminophen-related acute liver failure (ALF) cases has
been observed both in the United States (Larson, 2005) and Sweden (Wei, 2007), suggesting that
females with acute liver injury are either more predisposed to develop ALF or utilize prescription
and/or over-the-counter medications containing acetaminophen more frequently than men.
However, these data may be influenced by other factors as well including concomitant alcohol use,
9

concurrent medications, or nutritional status. Additionally, recent studies show the prevalence,
incidence, and morbidity risk of depressive disorders is higher among females than males (Piccinelli,
2000, Pratt, 2008), and depressive disorders can often lead to self-medication, often times
compounding the deleterious effects of the condition and leading to suicidal thoughts or actions
(Zwolinski, 2010). Furthermore, nearly half of all acetaminophen-related ALF cases are a result of
an intentional overdose (Larson, 2005).

Although not every acetaminophen-related ALF case

resulting from an intentional overdose may be attributed to a concomitant depressive disorder,
acetaminophen is also not likely the sole factor resulting in a greater predominance of ALF cases in
female than male humans. On the other hand, mouse models of APAP-induced hepatotoxicity are
bred and maintained in a tightly controlled environmental setting, without the confounding
influence of these added factors or conditions.

Sex Differences of Nrf2-Responsive Genes
NAD(P)H Quinone Oxidoreductase 1:

While there are no reports of sex differences of Nqo1

expression in mice, one recent study has reported sex differences in the rat. This study observed
significantly higher basal mRNA, protein, and enzymatic activity levels of Nqo1 in Sprague Dawley
female than male rats, and these differences remained significant following APAP administration
(Augustine, 2008). However, differences in the mRNA, protein, and enzymatic activity of Nqo1
were not observed in August Copenhagen x Irish (ACI) rat strains. While both rat strains are
commonly employed in drug-induced enzyme induction and toxicity studies, sex differences in
Nqo1 mRNA and protein expression and enzymatic activity levels are strain-dependent. This
finding can, therefore, serve as an important tool when using rat models for toxicity studies.

10

Multidrug Resistance-Associated Protein Transporters: It is known that Nrf2 plays a predominant role in
the hepatic induction of the Mrp family of proteins (Maher, 2005). Furthermore, one study has
shown that Mrp4 mRNA expression levels are more pronounced in female than male CD-1 mice at
a low dose of APAP (Masubuchi, 2011). The absence of a significant Mrp4 mRNA response at a
higher dose may be due to impaired gene regulation resulting from pronounced hepatocellular
necrosis.

Glutamate Cysteine Ligase: A greater number of studies suggest sex differences in glutamate cysteine
ligase. One study observed greater mRNA induction of Gclc in female than male CD-1 mice
following APAP administration at 300 mg/kg (Masubuchi, 2011). An earlier study also reported
greater APAP-induced hepatotoxicity in male than female Gclm wild-type C57BL/6 mice
(McConnachie, 2007).

Finally, a more recent study reported that pretreatment of mice with

buthionine sulfoximine (BSO), an inhibitor of glutamate cysteine ligase, potentiates APAP
hepatotoxicity in female mice. These findings suggest a role for glutamate cysteine ligase in the
differential susceptibility of male and female mice to APAP-induced hepatotoxicity. However,
glutamate cysteine ligase is involved in the formation of glutathione (GSH) which plays an important
role in the detoxification of NAPQI, the toxic reactive metabolite formed as a result of APAP
metabolism, and it remains unclear whether there is a differential expression of GSH between males
and females. One study shows no basal differences in hepatic GSH levels in overnight-fasted CD-1
male and female mice (Masubuchi, 2011). However, another study reports significantly lower basal
GSH levels in male than female mouse livers (Sheng, 2013). These variations in the literature may
be due to differences across strains and/or differences across experimental methodologies (e.g. time
points of analysis, overnight-fasting versus continued feeding).

11

While there is a small amount of literature already available that explores the differential
susceptibility of males and females to APAP-induced hepatotoxicity, many questions still remain
unanswered about the mechanism(s) involved in this differential susceptibility. Because many of the
cytoprotective genes associated with APAP hepatotoxicity are regulated by the nuclear transcription
factor Nrf2, it is important to understand the potential influence Nrf2 has on the differential
susceptibility of males and females to APAP-induced hepatotoxicity.

12

Chapter Two

Let’s Talk Sex: Is Nrf2 Responsible for Sex Differences in Susceptibility to
Acetaminophen-Induced Hepatotoxicity in Mice?

ABSTRACT
Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that positively
regulates the expression and activity of cytoprotective genes during periods of oxidative stress. It
has previously been shown that some of these cytoprotective genes are more highly expressed in
livers of female than male mice. This could explain previously reported sex-related differences in
susceptibility to acetaminophen (APAP) hepatotoxicity in mice, where females show greater
resistance to APAP hepatotoxicity. Here, we examined differences in basal mRNA and protein
expression for Nrf2 and Nrf2-dependent genes and measured glutathione (GSH) levels in naïve fed
wild-type (WT) male and female mice and overnight-fasted WT and Nrf2-null male and female mice
following either vehicle or APAP administration. Alanine aminotransferase (ALT) activity was also
measured as an indicator of hepatotoxicity. Hepatic mRNA and protein levels were measured by
quantitative PCR and western blotting, respectively. Basal Nrf2 mRNA expression was significantly
lower in livers of naïve female than male mice. In agreement with mRNA expression, basal Nrf2
protein expression was lower in livers of both naïve and overnight-fasted WT female than male
mice, with significance observed in livers of naïve mice. Basal mRNA expression of the Nrf2regulated gene NAD(P)H quinone oxidoreductase 1 (Nqo1) was significantly greater in livers of
overnight-fasted WT female than male mice, however, no significant differences between sexes for
the remaining Nrf2-regulated genes were observed. Interestingly, basal Nqo1 protein expression
was significantly higher in livers of naïve and overnight-fasted WT and Nrf2-null female than male
13

mice. Furthermore, a significantly greater induction of Nqo1 and multidrug resistance-associated
protein 4 (Mrp4) mRNA expression was observed in both naïve and overnight-fasted WT and Nrf2null female than male livers following APAP administration, resulting in significantly greater mRNA
expression of these genes in female than male livers. ALT activity was also significantly elevated in
both overnight-fasted WT and Nrf2-null male mice following APAP administration, but no
increases in ALT were observed in either genotype of female mice. These results indicate that other
factors, rather than Nrf2, are responsible for the lower susceptibility of female mice to APAP
hepatotoxicity.

INTRODUCTION
Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that positively
regulates the expression and activity of cytoprotective genes during periods of oxidative stress. In its
inactive state, Nrf2 is bound to Kelch-like ECH-associated protein 1 (Keap1) in the cytoplasm of
the cell (Itoh, 1999, Kang, 2004). However, in the presence of oxidative stress, Nrf2 dissociates
from Keap1 and translocates into the nucleus of the cell leading to the activation of antioxidant
response element (ARE)-mediated gene transcription. ARE-containing genes identified as targets of
Nrf2 are involved in a variety of cellular functions including drug metabolism, reactive oxygen
species scavenging, GSH homeostatsis, and efflux transport pathways (Nguyen, 2003). These genes
include, among others, NAD(P)H quinone oxidoreductase 1 (Nqo1), heme oxygenase 1 (Ho-1),
multidrug resistance-associated protein transporters (Mrp1-4), glutamate cysteine ligase catalytic
subunit (Gclc), and glutamate cysteine ligase modifier subunit (Gclm) (Aleksunes, 2007). An impaired
expression of these genes can increase the sensitivity of cells to oxidative damage. Previously, it has
also been shown that many of these genes are more highly expressed in the livers of female than
male mice (Masubuchi, 2011, Dai, 2006).
14

Acetaminophen (APAP) is a commonly used analgesic and antipyretic. APAP is also one of
the leading causes of acute liver failure in the United States (Reuben, 2010). Since the early 2000’s,
APAP has been attributed to approximately 50% of all acute liver failure cases across the United
States (Reuben, 2010). At therapeutic doses, the majority of APAP is metabolized in the liver by
glucuronidation and sulfation to APAP-GLU and APAP-SUL conjugates, respectively (Heard,
2008). Only a small portion of APAP, approximately 5%, is metabolized in the liver by cytochrome
P450 enzymes, Cyp1a2, Cyp3a11 (Cyp3a4 in humans), and Cyp2e1, to a toxic reactive metabolite Nacetyl-p-benzoquinone imine (NAPQI) (Dahlin, 1984) which is efficiently inactivated by hepatic
glutathione (GSH) pools (Chen, 2003). At toxic doses, however, the glucuronidation and sulfation
pathways become saturated and an excess amount of NAPQI is formed leading to a rapid depletion
of hepatic GSH. NAPQI, in turn, covalently binds to cellular macromolecules resulting in the
production of reactive oxygen species and leading to oxidative stress and hepatocellular damage
(Jaeschke, 2006). Currently, N-Acetyl cysteine (NAC), a precursor to GSH, is the only standard
therapy used to prevent and decrease APAP-induced hepatotoxicity. However, this treatment is
administered only in a hospital setting and must be administered within 8 hrs following overdose to
be most effective (Algren, 2008). In the case of accidental overdose, however, ALF may not be
evident within 8 hrs, at which point administration of NAC is no longer beneficial (Larson, 2005).
APAP has been shown to lead to the nuclear accumulation of Nrf2 in mouse liver
(Goldring, 2004). Various studies have also shown increased expression of downstream Nrf2 target
genes in mouse liver following APAP administration including Nqo1, Ho-1, and Gclc (Goldring, 2004,
Aleksunes, 2006b). Furthermore, Nrf2-null mice exhibit enhanced hepatocellular injury compared
to their wild-type counterparts following APAP administration (Chan, 2001, Enomoto, 2001),
suggesting a pivotal hepatoprotective role for Nrf2 in APAP-induced hepatotoxicity.
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Sex is known to play an important role in drug absorption, metabolism, distribution, and
excretion (Morris, 2003, Tanaka, 1999). Previous work has shown sex differences in susceptibility to
APAP hepatotoxicity in mice, however, the mechanism(s) underlying these sex differences remains
unknown. Recent studies have shown that male C57BL/6 mice are more susceptible to APAPinduced hepatotoxicity than their female counterparts (Dai, 2006, McConnachie, 2007). However,
in CD-1 mice, one study reported no sex differences with respect to APAP-induced hepatotoxicity
(Hoivik, 1995), while a more recent study suggests that female CD-1 mice are more resistant to
APAP-induced hepatotoxicity than their male counterparts (Masubuchi, 2011). The latter study
observed elevated alanine aminotransferase (ALT) activity in male CD-1 mice but not in female CD1 mice following APAP administration, and histological examination of liver tissue sections at 24 hrs
following APAP administration revealed hemorrhage and centrilobular necrosis only in the male
mice.

For these reasons, male mouse models are more often employed in APAP-induced

hepatotoxicity studies than female mouse models. This subsequently results in only a small amount
of literature exploring the differential susceptibility of male and female mice to APAP-induced
hepatotoxicity. Interestingly, in humans, a higher female predominance of acetaminophen-related
acute liver failure (ALF) cases has been observed both in the United States (Larson, 2005) and
Sweden (Wei, 2007).

These data, however, may be influenced by concomitant alcohol use,

concurrent medications, or nutritional status, for example.
The present study aims to explore sex differences in the expression of various cytoprotective
genes involved in APAP-induced hepatotoxicity in C57BL/6J mice. Here, we hypothesized that
resistance to APAP-induced hepatotoxicity by female mice is due to higher basal and inducible
expression of Nrf2 and Nrf2-dependent genes. We examined alanine aminotransferase (ALT) levels
in male and female mice, measured mRNA and protein expression for Nrf2 and Nrf2-dependent
genes, and measured hepatic GSH levels in male and female mice. This study will aid in the
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identification of potential new therapeutic gene targets for the treatment and prevention of druginduced liver injury.

MATERIALS AND METHODS
Reagents. APAP was purchased from Sigma-Aldrich (St. Louis, MO).

Animals and Treatment. Male and female WT C57BL/6J mice were purchased from the Jackson
Laboratory (Bar Harbor, ME). Nrf2-/- (Nrf2-null) mice with a C57BL/6J background were kindly
provided by Dr. Angela Slitt from the University of Rhode Island. The mice utilized were age
matched from 8.5 to 10.5 weeks of age. All mice were housed and bred at the University of
Connecticut in a temperature-, light-, and humidity-controlled environment that is accredited by the
Association for Assessment and Accreditation of Laboratory Animal Care. Mice were maintained
on standard laboratory chow and had free access to water. Male and female WT mice were either
fasted overnight or maintained on the laboratory chow. Male and female Nrf2-null mice were fasted
overnight. APAP was dissolved in saline (pH 8.0). Mice received either no treatment or were
administered APAP (200 mg/kg, 400 mg/kg or 600 mg/kg, i.p.) or saline as a vehicle treatment.
Plasma and liver were collected at various time points. A portion of the liver was fixed in 10% zinc
formalin and the remaining liver tissue was snap frozen in liquid nitrogen. Frozen tissues were
stored at −80°C until assayed. All animal studies were conducted in accordance with National
Institutes of Health standards and the Guide for the Care and Use of Laboratory Animals. Studies were
approved by the University of Connecticut Institutional Animal Care and Use Committee (IACUC
Protocol no. A12-050).
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Assessment of Hepatotoxicity. Plasma ALT activity was determined as a biochemical indicator of
hepatocellular necrosis. Infinity ALT Liquid Stable Reagent (Thermotrace, Melbourne, Australia)
was used according to the manufacturer’s protocol. Hepatotoxicity was confirmed by histological
examination of liver tissue sections. Formalin-fixed tissue sections were embedded in paraffin,
mounted onto glass slides, stained with hematoxylin-eosin, and examined for histopathological
changes by a board-certified veterinary pathologist.

Preparation of Crude Membrane, Microsomal, Cytosolic, and Nuclear Fractions. Livers were homogenized in
sucrose-Tris (ST) buffer (0.25 M sucrose, 10 mM Tris–HCl, pH 7.4) containing 50 μg/ml aprotonin
and centrifuged at 100,000 × g for 60 min at 4°C. The resulting pellet constituted the crude
membrane fraction and was resuspended in ST buffer. For isolation of microsomes, homogenates
were first centrifuged at 10,000 × g for 20 min at 4°C. The supernatant was then centrifuged at
100,000 × g for 60 min. ST buffer was used to resuspend the microsomal pellet. Liver cytosolic and
nuclear extracts were prepared using the NE-PER Nuclear Extraction Kit according to the
manufacturer’s directions (Pierce Biotechnology, Rockford, IL). Protein concentrations were
determined using Bio-Rad protein assay reagents (Bio-Rad Laboratories, Hercules, CA). Bovine
serum albumin (BSA) (Sigma-Aldrich, St. Louis, MO) was used as a standard.

Western Blot Analysis. Cytosolic and nuclear proteins were boiled for 10 minutes. Proteins were
electrophoretically resolved using polyacrylamide gels (8-12% resolving, 5% stacking) and
transblotted onto PVDF-Plus membrane (Micron Separations, Westboro, MA). Immunochemical
detection of Nrf2, Nqo1, Ho-1, Gclc, Gclm, Mrp3, and Mrp4 proteins are described in Table 2.
Briefly, membranes were blocked with 5% non-fat dry milk (NFDM) in Tris-buffered saline0.1%Tween-20 (pH 7.4) (TBS-Tw) for 1 h and incubated overnight with the primary antibody
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diluted in blocking buffer. A species-appropriate peroxidase-labeled secondary antibody (Sigma, St.
Louis, MO) was diluted in blocking buffer and incubated with blots for 1 h. Protein-antibody
complexes were detected using a chemiluminescent kit (Thermo Scientific, IL) followed by exposure
to X-ray film. Intensity values were normalized to TBP for Nrf2 and β-actin for remaining proteins.

Quantitative RT-PCR. Real time PCR (qRT-PCR) was carried out using an Applied Biosystems 7500
Fast qRT-PCR Machine. Primers for Nrf2, Keap1, Nqo1, Ho-1, Gclc, Gclm, Mrp3, and Mrp4 were
obtained from Integrated DNA Technologies and gene levels were normalized to β-Tubulin. Primer
sequences are shown in Table 3.

Measurement of GSH Levels. Total GSH was measured as previously described (Rahman, 2006).
Briefly, livers were homogenized in 500 μl of buffer containing 0.2% Triton-X 100 and 0.6%
sulfosalicyclic acid in 0.1 M potassium phosphate buffer with 5 mM EDTA disodium salt (KPE),
pH 7.5. 20 μl of standards and samples were pipetted into a 96-well microtiter plate. 60 μl of βNADPH (Sigma, St. Louis, MO) was added followed by 120 μl of 1:1 3.33 U/ml glutathione
reductase (Sigma, St. Louis, MO) with 0.67 mg/ml 5,5’-Dithiobis (2-nitrobenzoic acid, DTNB).
Yellow 5-thio-2-nitrobenzoic acid (TNB) formation was monitored spectrophotometrically at
412 nm. The rate of formation of TNB is proportional to the concentration of GSH in the sample.

Statistical Analysis. Data were given as mean ± SD. Data were analyzed using the Student t-test or
one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparison test to determine
significant differences between group means. Significance was set at p < 0.05.
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RESULTS
Plasma ALT activity and histopathology in WT mice following APAP
APAP-induced hepatocellular injury was assessed by plasma ALT levels and confirmed by
histological examination of liver tissue sections. At 400 mg APAP/kg, significant elevations in
plasma ALT activity at 4 and 24 hrs were detected in male WT mice (Figure 1A). However, ALT
activity at 4 and 24 hrs after APAP did not increase in female WT mice. Histological examination
and grading of WT male and female liver tissue sections at 4 and 24 hrs after treatment with APAP
was further indicative of hepatocellular damage in male but not female WT mice. Centrilobular
necrosis was observed in male livers at 4 hrs after treatment with APAP and this damage was even
further pronounced at 24 hrs (Figure 1D-E). No significant damage was observed in female livers at
either time point (Figure 1B-C). Histological grading further confirms these results (Table 1). In
Table 1, liver sections with grades higher than 2 are considered to have significant injury. Treatment
with 400 mg APAP/kg resulted in significant injury in 80% of male WT mice at 24 hrs following
APAP treatment, however, no significant injury in female livers was observed.

Hepatic mRNA expression of Nrf2 and Nrf2-dependent genes in naïve WT mouse livers
Hepatic mRNA expression was measured for Nrf2, Keap1, and Nrf2-dependent genes Nqo1,
Ho-1, Gclc, Gclm, Mrp3, and Mrp4 (Figure 2A-H). Nrf2 hepatic mRNA levels in naïve WT females
were significantly lower compared to male values (Figure 2A). No significant differences in mRNA
expression between female and male livers were observed for the remaining genes. These results are
consistent with previous literature which shows similar basal mRNA levels of Gclc in male and
female mouse livers (Masubuchi, 2011). Masubuchi (2011) also showed significantly greater basal
mRNA expression of Mrp4 in female mouse livers compared to male livers. In the current study,
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however, while greater basal mRNA expression of Mrp4 was observed in female livers compared to
male livers, this difference was not significant.

Hepatic mRNA expression of Nrf2 and Nrf2-dependent genes in overnight-fasted WT
mouse livers following APAP
Hepatic mRNA expression was measured for Nrf2, Keap1, and Nrf2-dependent genes Nqo1,
Ho-1, Gclc, Gclm, Mrp3, and Mrp4 (Figure 3A-H). Hepatic basal Nrf2 mRNA expression was slightly
higher in females compared to males, although this difference was not significant. Consistent with
the naïve WT mouse data, no significant differences in basal mRNA expression in livers of
overnight-fasted WT female and male mice were observed for the Nrf2-dependent genes examined,
with the exception of Nqo1. Hepatic basal mRNA expression of Nqo1 was significantly greater in
female livers compared to male values at 4 hrs (Figure 3C). In naïve WT female livers, basal mRNA
expression of Nqo1 was greater than in naïve WT male livers, although this difference was not
significant (Figure 2C). The significant difference in hepatic basal mRNA expression of Nqo1 in the
overnight-fasted WT mice may be a consequence of fasting-induced oxidative stress; however,
previous literature shows no significant difference in basal mRNA expression of Nqo1 in liver
between sexes for fed versus 24h-fasted mice (Zhang, 2013).
A significant induction in Gclc mRNA levels was also observed in livers of overnight-fasted
WT females at 4 hrs following APAP administration (Figure 3E). This is consistent with previous
work which shows elevated Gclc mRNA levels in livers of female mice following APAP
administration (Masubuchi, 2011). Mrp4 mRNA expression was also greatly elevated in livers of
overnight-fasted WT females at 24 hrs following APAP administration.

Mrp1-4 are plasma

membrane efflux transporter proteins that are believed to be involved in the antioxidant response
through mediating the efflux of xenobiotics from the liver into the bile or blood (Klaassen, 2005).
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Previous literature has shown Mrp4 to be a highly inducible antioxidant response protein in the liver
of male and female mice following APAP administration (Aleksunes, 2008, Masubuchi, 2011).

Hepatic protein expression of Nrf2 and Nrf2-dependent genes in naïve WT mouse livers
Hepatic protein expression was measured for Nrf2 and Nrf2-dependent genes Nqo1, Gclc,
Gclm, Mrp3, and Mrp4 (Figure 4A-F). Similar to mRNA expression, Nrf2 protein expression was
significantly lower in female livers compared to male livers (Figure 4A). Hepatic protein expression
for the remaining genes, except Gclc, followed a similar pattern with mRNA expression. That is, if
mRNA expression was lower in female livers than male livers, protein expression was also observed
to be lower in female livers compared to male livers.

Significance in protein expression was

observed for Nqo1, Gclc, Gclm, and Mrp3. While female livers showed significantly greater Nqo1
protein expression than male livers (Figure 4B), Gclm and Mrp3 protein expression was significantly
lower in female than male livers (Figure 4D-E). Gclc protein expression was significantly higher in
female than male livers (Figure 4C), though Gclc mRNA expression, while not statistically significant,
appeared lower in female livers compared to male livers (Figure 2E).

Hepatic protein expression of Nrf2 and Nrf2-dependent genes in overnight-fasted WT
mouse livers following APAP
Hepatic protein expression was measured for Nrf2 and Nrf2-dependent genes Nqo1, Ho-1,
Gclc, Gclm, Mrp3, and Mrp4 (Figure 5A-N). Similar to protein expression in naïve WT mouse
livers, Nrf2 protein expression was less pronounced in livers of overnight-fasted WT female than
male mice following either vehicle or APAP administration.

Of the Nrf2-dependent genes

examined, females did not exhibit a higher global expression of these genes. Consistent with mRNA
expression, basal protein expression of Nqo1 was significantly greater in female livers compared to
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male livers at 4 hrs following vehicle treatment (Figure 5C). Female livers also showed significantly
greater Mrp4 basal protein expression than male livers at both 4 hrs and 24 hrs following vehicle
treatment (Figure 5M-N). No significant differences in basal protein expression between sexes were
observed for the remaining genes. A significant induction in Ho-1 protein expression was observed
in both sexes at 24 hrs following APAP administration (Figure 5D).

This is consistent with

previous work in our lab which shows Ho-1 is a highly inducible stress protein (Aleksunes, 2008).
Consistent with protein expression in naïve WT livers, basal protein expression of Gclc was
higher in livers of overnight-fasted WT females compared to males, although this difference was not
significant. Gclc protein expression was significantly decreased in female livers at 4 hrs following
APAP administration (Figure 5G), but returned to basal levels at 24 hrs (Figure 5H). No significant
differences in Gclc protein expression in male livers were observed following APAP administration.
These results are consistent with previous studies showing Gclc protein expression is significantly
reduced in female mouse livers following APAP administration while no significant differences in
male livers were observed (Sheng, 2013). Furthermore, although not significant, Gclm protein
expression was higher in female livers compared to male livers at 4 hrs and 24 hrs following either
vehicle or APAP administration (Figure 5I-J).

Gclc and Gclm are enzymes involved in the

production of GSH, an important detoxification pathway in APAP hepatotoxicity. These data
suggest a greater propensity for females to produce more GSH than males following APAP
treatment.

Hepatic glutathione measurement in WT mice following APAP
To investigate potential sex differences in hepatic GSH levels, total GSH was measured, as
described in the materials and methods, in livers of naïve WT male and female mice as well as
overnight-fasted WT male and female mice following either vehicle or APAP administration. No
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significant differences in basal GSH levels were observed between livers of naïve or overnight-fasted
WT male and female mice (Figures 6-7). However, a significantly greater reduction in GSH at 4 hrs
following APAP administration was observed in overnight-fasted WT male livers compared to
female livers (Figure 7). This is consistent with observations of lower toxicity and liver damage in
female livers compared to male livers. Glutathione levels rebound in both sexes at 24 hrs following
APAP administration (Figure 7), consistent with an increase in Gclc mRNA expression in both sexes
at 4 hrs following APAP administration (Figure 3E).

Plasma ALT activity and histopathology in Nrf2-null mice following APAP
To better understand whether Nrf2 is responsible for the sex differences in susceptibility of
male and female mice to APAP-induced hepatotoxicity, ALT activity was measured in Nrf2-null
male and female mice following APAP treatment. At 200 mg APAP/kg, significant elevation in
plasma ALT activity at 24 hrs was detected in male Nrf2-null mice (Figure 8A). However, no
significant change in ALT activity was observed in females of the same genotype (Figure 6A).
Histological examination and grading of liver tissue sections from male and female Nrf2-null mice at
24 hrs following APAP administration further confirms these results (Figures 8C-D, Table 1).
Treatment with 200 mg APAP/kg resulted in significant injury in 60% of male Nrf2-null mice
compared to 0% of female Nrf2-null mice (Table 1).

Furthermore, at 400 mg APAP/kg,

significantly elevated ALT activity was still not observed in female Nrf2-null mice (Figure 8B) and
histological grading did not detect significant injury in female Nrf2-null mice following APAP
treatment at 400 mg/kg (Table 1). However, at 600 mg APAP/kg, significantly elevated ALT
activity was observed in female Nrf2-null mice (Figure 8B). Histological examination and grading
further confirmed the presence of hepatocellular damage in liver tissue sections of female Nrf2-null
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mice following APAP treatment at 600 mg APAP/kg (Figure 8F, Table 1). Significant injury in 75%
of female Nrf2-null mice resulted following treatment with 600 mg APAP/kg (Table 1).

Hepatic mRNA expression of Nrf2-dependent genes in Nrf2-null mouse livers following
APAP
Hepatic mRNA expression was measured for Keap1 and Nrf2-dependent genes Nqo1, Ho-1,
Gclc, Gclm, Mrp3, and Mrp4 (Figure 9A-G). Significant induction of Ho-1 was observed in male livers
at 24 hrs following APAP treatment (Figure 9B). Ho-1 catabolizes prooxidant heme to carbon
monoxide, biliverdin, and free iron, thereby preventing free heme from facilitating the formation of
reactive oxygen species (Aleksunes, 2007). These results are consistent with previous literature that
show Ho-1 is upregulated following oxidative stress and cellular injury (Guo, 2001, Aleksunes, 2008).
Similar to the overnight-fasted WT mouse livers, Nrf2-null female mouse livers showed
significant induction of Nqo1 and Mrp4 mRNA expression at 24 hrs following APAP treatment
(Figure 9C & G).

Furthermore, at 24 hrs following APAP treatment, female livers showed

significantly greater mRNA expression of Nqo1, Mrp3, and Mrp4 than male livers (Figure 9C, F &
G). These data suggest that other mechanisms in addition to Nrf2 or in compensation for the
absence of Nrf2 may regulate the transcription of Nqo1 and Mrp4 in females.

Hepatic protein expression of Nrf2-dependent genes in Nrf2-null mouse livers following
APAP
Hepatic protein expression was measured for Nrf2-dependent genes Nqo1, Ho-1, Gclc,
Gclm, Mrp3, and Mrp4 (Figure 10A-F). Nrf2-null female livers showed significantly greater Nqo1
basal protein expression than their male counterparts at 24 hrs following vehicle treatment (Figure
10B).

No significant differences between sexes were observed for the remaining genes.
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A

significant reduction in Gclc protein expression was observed in female livers at 24 hrs following
APAP treatment (Figure 10C). A similar reduction was observed at 4 hrs following APAP treatment
in female overnight-fasted WT mouse livers (Figure 5G).

Hepatic glutathione measurement in Nrf2-null mice following APAP
Total GSH was measured in livers of Nrf2-null male and female mice following either
vehicle or APAP administration. A significantly greater reduction in GSH was observed in male
than female livers at 24 hrs following APAP treatment (Figure 11).

This is consistent with

observations in livers of overnight-fasted WT male and female mice (Figure 7) and observations of
lower toxicity and liver damage in Nrf2-null female than male livers.
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Figure 1. Sex differences in APAP hepatotoxicity in mice. Male and female mice were sacrificed at
4 and 24 hrs following APAP administration. (A) Serum ALT activity in overnight-fasted WT mice
following APAP administration (400mg/kg, i.p.). Data are presented as mean ± SD (n = 6 animals).
Data were analyzed using ANOVA followed by Tukey’s multiple comparison test. Asterisks (*)
represent statistical differences (p<0.05) between groups. (B-E) Histopathology of liver sections.
Liver sections from male and female overnight-fasted WT mice at 4 and 24 hrs following vehicle or
APAP treatment were subjected to hematoxylin-eosin staining (10x final magnification). Samples
are as follows: B, female/WT/400mg/kg APAP/4h; C, female/WT/400mg/kg APAP/24h; D,
male/WT/400mg/kg APAP/4h; E, male/WT/400mg/kg APAP/24h. Vehicle not shown.
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B
A

Male

Alanine Aminotransferase (IU/L)

2000

Female

*

1800

*
*

*

*

C

1600
1400
1200
1000

D

800
600
400
200
0

Vehicle

APAP
4h

Vehicle

APAP
24h
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E

Table 1. Histopathological analysis of livers from APAP-treated WT and Nrf2-null mice. Livers
were removed from WT and Nrf2-null mice 4 and 24 hrs following vehicle or APAP (200 mg/kg,
400 mg/kg, or 600 mg/kg) administration and fixed in 10% formalin prior to paraffin embedding
and staining with hematoxylin and eosin. Liver sections were evaluated for the severity of
degenerative and necrotic changes in the centrilobular regions as previously described (Manautou et
al., 1994, Aleksunes et al., 2005). Liver samples with grades greater than 2 are considered to have
significant injury. Data were rank ordered prior to statistical analysis. Asterisks (*) represent a
statistical difference (p < 0.05) from control mice of the same genotype and sex. Daggers (†)
represent a statistical difference (p < 0.05) from WT mice of the same treatment and sex.
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Histological Grade
WT
4 hrs
Male
Vehicle
400 mg APAP/kg
Female
Vehicle
400 mg APAP/kg
24 hrs
Male
Vehicle
400 mg APAP/kg
Female
Vehicle
400 mg APAP/kg

0

1

2

3

4

5

%>2

Total

0
0*

3

3
4

0
0

3
4

3

0
80*

3

5

0
0

3
5

4

1

1

0
60*

3

1

0
0

6
4

2

1

3
5

1

4

3

5

5

Nrf2-null
24 hrs
Male
Vehicle
200 mg APAP/kg
Female
Vehicle
200 mg APAP/kg
400 mg APAP/kg
600 mg APAP/kg

4
1

2

6
1

1

1

2

30

1

5

20

5

*

4

75

Figure 2. Messenger RNA expression of Nrf2, Keap1, and Nrf2-regulated genes in male and female
naïve WT mouse livers. Data are presented as mean ± SD. Data were analyzed using the Student ttest. Asterisks (*) represent statistical differences (p<0.05) between sexes.
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Female (n=6)
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Female (n=6)

Gclm
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0.50

0.00
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Male (n=6)

1.50

0.00

Female (n=6)

Keap1

1.50

0.00

Female (n=6)

Gclc

Male (n=6)
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0.00

Female (n=6)

1.50

0.00

G

Male (n=6)

Hepatic mRNA Fold Change

Hepatic mRNA Fold Change

1.80

0.00

E

*

1.50

0.00

C

B

Nrf2

Hepatic mRNA Fold Change

1.80

Hepatic mRNA Fold Change

Hepatic mRNA Fold Change

A

Male (n=5)
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Figure 3. Hepatic messenger RNA expression of Nrf2, Keap1, and Nrf2-regulated genes in vehicleand APAP-treated (400 mg/kg, i.p.) overnight-fasted WT male and female mice. Data are presented
as mean ± SD (n = 6 animals). Data were analyzed using ANOVA followed by Tukey’s multiple
comparison test. Asterisks (*) represent statistical differences (p<0.05) between groups.
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*

30.00

0.00

APAP

Mrp4

Vehicle

APAP
24h

Figure 4. Western blots for Nrf2 and Nrf2-regulated genes were performed using liver membrane
(Mrp3 and Mrp4), cytosolic (Nqo1, Gclc, and Gclm), and nuclear (Nrf2) preparations from naïve
WT male and female mice. Human hepatocyte-derived HCO4 cells treated with 100μM tBHP for 2
hrs were used as a positive control for Nrf2 detection. Nrf2-null mouse liver tissue was used as a
negative control for Nrf2 detection. Equal protein loading was confirmed by detection of TBP for
Nrf2 and β-actin. Data are presented as blots (upper panel) and as mean ± SD (n = 6 animals)
(lower panel). Data were analyzed using the Student t-test. Asterisks (*) represent statistical
differences (p<0.05) between sexes.
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Figure 5. Western blots for Nrf2 and Nrf2-regulated genes were performed using liver membrane
(Mrp3 and Mrp4), cystolic (Nqo1, Ho-1, Gclc, and Gclm), and nuclear (Nrf2) preparations from
vehicle- and APAP-treated (400 mg/kg, i.p.) overnight-fasted WT male and female mice. Human
hepatocyte-derived HCO4 cells treated with 100μM tBHP for 2 hrs were used as a positive control
for Nrf2 detection. Equal protein loading was confirmed by detection of TBP for Nrf2 and β-actin.
Data are presented as blots (upper panel) and as mean ± SD (n = 3 animals) (lower panel). Data
were analyzed using ANOVA followed by Tukey’s multiple comparison test. Asterisks (*) represent
statistical differences (p<0.05) between groups.
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Figure 6. GSH content in naïve wild-type mouse livers. Hepatic GSH levels were measured in male
and female naïve WT mice. Data were analyzed using the Student t-test. Data are presented as
mean ± SD (n=6 animals). Data were analyzed using the Student t-test. Asterisks (*) represent a
statistical difference (p<0.05) between sexes.
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Figure 7. Hepatic GSH levels were measured in vehicle- and APAP-treated (400 mg/kg, i.p.)
overnight-fasted WT male and female mice. Data are presented as mean ± SD (n=6 animals). Data
were analyzed using ANOVA followed by Tukey’s multiple comparison test. Asterisks (*) represent
statistical differences (p<0.05) between groups.
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Figure 8. Sex differences in APAP hepatotoxicity in mice. Male and female mice were sacrificed at
24 hrs following APAP administration. (A) Serum ALT activity in Nrf2-null mice at 24 hrs
following APAP administration (200mg/kg, i.p., n = 4 to 5 animals). (B) Serum ALT activity in
Nrf2-null female mice at 24 hrs following APAP administration (400mg/kg and 600mg/kg, i.p., n =
4 to 5 animals). Data are presented as mean ± SD. Data were analyzed using ANOVA followed by
Tukey’s multiple comparison test. Asterisks (*) represent statistical differences (p<0.05) between
groups. (C-F) Histopathology of liver sections. Liver sections from male and female Nrf2-null mice
at 24 hrs following vehicle or APAP administration were subjected to hematoxylin-eosin staining
(10x final magnification). Samples are as follows: C, female/Nrf2-null/200mg/kg APAP/24h; D,
male/Nrf2-null/200mg/kg APAP/24h; E, female/Nrf2-null/400mg/kg APAP/24h; F,
female/Nrf2-null/600mg/kg APAP/24h. Vehicle not shown.
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Figure 9. Hepatic messenger RNA expression of Keap1, and Nrf2-regulated genes in vehicle- and
APAP-treated (200 mg/kg, i.p.) male and female Nrf2-null mice. Data are presented as mean ± SD
(n = 4 to 5 animals). Data were analyzed using ANOVA followed by Tukey’s multiple comparison
test. Asterisks (*) represent statistical differences (p<0.05) between groups.
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Figure 10. Western blots for Nrf2-regulated genes were performed using liver membrane (Mrp3
and Mrp4) and cytosolic (Nqo1, Gclc, and Gclm) preparations from Nrf2-null male and female
mice. Equal protein loading was confirmed by detection of β-actin. Data are presented as blots
(upper panel) and as mean ± SD (n = 3 animals) (lower panel). Data were analyzed using ANOVA
followed by Tukey’s multiple comparison test. Asterisks (*) represent statistical differences (p<0.05)
between groups.
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Figure 11. Hepatic GSH levels were measured in vehicle- and APAP-treated (200 mg/kg, i.p.) male
and female Nrf2-null mice at 24h. Data are presented as mean ± SD (n=4 to 5 animals). Data were
analyzed using ANOVA followed by Tukey’s multiple comparison test. Asterisks (*) represent
statistical differences (p<0.05) between groups.
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Table 2 - Methods For Immunoblot Analysis

Nuclear
Cytosolic
Cytosolic
Cytosolic
Cytosolic
Membrane
Membrane
Nuclear
Cytosolic

Cell Fraction
1:1000
1:1000
1:2000
1:20,000
1:20,000
1:2000
1:2000
1:1000
1:3500

Primary Antibody
Concentration
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5% BSA
2% NFDM
1% NFDM
2% NFDM
2% NFDM
2% NFDM
2% NFDM
2% NFDM
2% NFDM

Primary Antibody
Blocking Buffer
anti-rabbit
anti-goat
anti-rabbit
anti-rabbit
anti-rabbit
anti-rat
anti-rat
anti-mouse
anti-rabbit

Secondary Antibody
f

Sigma (A4914)
f
Sigma (A8919)
f
Sigma (A4914)
f
Sigma (A4914)
f
Sigma (A4914)
f
Sigma (A9037)
f
Sigma (A9037)
f
Sigma (A4416)
Sigmaf (A4914)

Secondary Antibody
Source
1:1000
1:10,000
1:2000
1:20,000
1:20,000
1:2000
1:2000
1:3000
1:2000

Secondary Antibody
Concentration

2% NFDM
2% NFDM
2% NFDM
2% NFDM
2% NFDM
2% NFDM
2% NFDM
2% NFDM
2% NFDM

Secondary Antibody
Blocking Buffer

~110
~32
~33
~75
~28
~180
~160
~38
~42

Protein Molecular
Weight (kDa)

Table 3 - Primer Sequences for Quantitative RT-PCR
Gene
Nrf2
Keap1
Nqo1
Ho-1
Gclc
Gclm
Mrp3
Mrp4

Forward:
Reverse:
Forward:
Reverse:
Forward:
Reverse:
Forward:
Reverse:
Forward:
Reverse:
Forward:
Reverse:
Forward:
Reverse:
Forward:
Reverse:

Primer Sequences
5’ – TCTATGTCTTGCCTCCAAAGG – 3’
5’ – CTCAGCATGATGGACTTGGA – 3’
5’ – GGCAGTGTGACAGGTTGAAG – 3’
5’ – GATCGGCTGCACTGAACTG – 3’
5’ – TTTAGGGTCGTCTTGGCAAC – 3’
5’ – GTCTTCTCTGAATGGGCCAG – 3’
5’ – GAGCCTGAATCGAGCAGAAC – 3’
5’ – CCTTCAAGGCCTCAGACAAA – 3’
5’ – CTGCACATCTACCACGCAGT – 3’
5’ – TTCATGATCGAAGGACACCA – 3’
5’ – CGGGAACCTGCTCAACTG – 3’
5’ – TTGGGAACTCCATTCATTCA – 3’
5’ – AGTGGCTGTGATAGTCTTGCTGATA – 3’
5’ – CCGTTCAGGATCTCGCTCAT – 3’
5’ – ACCTCTGCTCGCGCGTGTTCT – 3’
5’ – CCAGTACCGTTGAAGCTCCTCTCC – 3’
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DISCUSSION
Nrf2 regulates a plethora of genes shown to protect against drug-induced liver toxicity
following toxic doses of APAP (Aleksunes, 2007). Furthermore, sex differences in susceptibility to
APAP-induced hepatotoxicity have also been reported, where female mice show greater resistance
to APAP-induced hepatotoxicity than their male counterparts. In the present study, we have
demonstrated that Nrf2 is not responsible for this sex difference. Lower Nrf2 mRNA and protein
expression was observed in livers of naïve WT female mice as well as overnight-fasted WT female
mice following vehicle- or APAP-treatment than in livers of male mice. Most notably, while ALT
activity was significantly elevated in both WT and Nrf2-null male mice following APAP
administration, no increases in ALT were observed in either genotype of female mice.
Interestingly, hepatic basal and APAP-inducible mRNA levels of Nqo1 and Mrp4 were
consistently higher in naïve and overnight-fasted WT and Nrf2-null females than males. This
finding suggests that other factors differentially expressed in male and female mice, with greater
expression in females than males, may regulate the transcription of these two genes, thereby
resulting in greater resistance of female than male mice to APAP-induced hepatotoxicity. Future
studies are needed to better understand the sex-dependent susceptibility of mice to APAP
hepatotoxicity.
In addition to Nrf2, other nuclear transcription factors including peroxisome proliferatoractivated receptor alpha (PPARα), aryl hydrocarbon receptor (AhR), and c-Jun N-terminal kinase
(JNK) also regulate the expression and activity of many cytoprotective genes associated with APAP
hepatotoxicity. For example, JNK facilitates the transcription of genes involved in cytoprotection
containing activator protein-1 (AP-1) binding sites within their promoter regions including
Glutathione S-Transferases (Gsts) (Elsby, 2003). APAP is known to induce AP-1 binding activity,
suggesting that JNK may play a protective role against APAP-induced hepatotoxicity. Interestingly,
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recent literature has shown 10-fold greater basal expression of mRNA for the Gst isoform Gstπ in
livers of male mice compared to females (Dai, 2006) and there is evidence that Gstπ may be a direct
inhibitor of JNK (Elsby, 2003). Recent studies have also shown that Gstπ-null mice show increased
resistance to APAP-induced hepatotoxicity (Henderson, 2000) and the absence of Gstπ elevates the
expression of Ho-1 in liver (Elsby, 2003). Gstπ is the most abundant Gst isoform in mouse liver
(Kitteringham, 2003). Further research is necessary to understand whether sex differences in Gstπ
expression may influence JNK expression and sex-dependent susceptibility to APAP hepatotoxicity.
Recent literature has also demonstrated the protective effect of 17β-Estradiol against APAPinduced hepatotoxicity (Chandrasekaran, 2011). Estrogens are known to elicit antioxidant effects,
protecting numerous tissues including the liver (Huh, 1994) from oxidative stress-induced damage.
Estradiol has been shown to significantly reduce malondialdehyde (MDA) levels in rats and inhibit
iron-mediated lipid peroxidation in rat liver microsomes (Huh, 1994). MDA is a thiobarbituric acid
reactive substance (TBAR) formed as a byproduct of lipid peroxidation. Iron is well known to be
involved in the initiation and/or progression of lipid peroxidation in the liver, particularly through
the Fenton reaction resulting in the production of the free radical and powerful oxidant, the
hydroxyl radical. A study by Huh (1994) showed a pronounced sex difference in lipid peroxide
levels in rats, with male rats exhibiting a greater level of lipid peroxides than female rats. Literature
has also suggested a synergistic interaction between 17β-Estradiol and Interleukin-6 (Il-6), an
inflammatory cytokine that aids in stimulating an immune response. Il-6 promotes sex bias in
experimental drug-induced liver injury (DILI) by reducing regulatory T cells (Tregs) (Cho, 2013).
Additional studies need to be performed to better understand how 17β-Estradiol may contribute to
sex-related differences in susceptibility to APAP-induced hepatotoxicity.
The present study demonstrates that Nrf2 is not responsible for the resistance of female
mice to APAP-induced hepatotoxicity and indicates that other mechanisms must contribute to this
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sex difference. Future studies will allow for a better understanding of the different mechanisms that
may contribute to the differential susceptibility of male and female mice to APAP-induced
hepatotoxicity, and the identification of new gene targets involved in APAP hepatotoxicity will
create opportunities for the development of new therapeutic interventions to aid in the prevention
and treatment of drug-induced liver injury.
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Chapter Three

Summary

Sex is known to play an important role in drug absorption, metabolism, distribution, and
excretion (Morris, 2003, Tanaka, 1999). It is, therefore, imperative when studying drug toxicity to
understand the differences in susceptibility of drugs between males and females. In turn, clinicians
can better adjust dosages of pharmaceuticals to compensate for any differences between sexes. The
work presented in this thesis explores the role of Nrf2, a nuclear transcription factor that positively
regulates the expression and activity of cytoprotective genes during periods of oxidative stress, in the
differential susceptibility of males and females to APAP-induced hepatotoxicity. This work will aid
in the progression of identifying new potential gene targets involved in APAP hepatotoxicity,
allowing for future opportunities to develop new therapeutic interventions aiding in the prevention
and treatment of drug-induced liver injury.
Previous work has shown differences in susceptibility of male and female mice to APAPinduced hepatotoxicity, where female mice show greater resistance to APAP-induced hepatotoxicity
than their male counterparts, however, the mechanism(s) underlying these sex differences remains
unknown. Current literature reports sex differences in various genes involved in cytoprotection
(Dai, 2006, McConnachie, 2007, Masubuchi, 2011, Sheng, 2013). Many of these genes are more
highly expressed in females than males and are transcriptionally regulated by Nrf2. Therefore, the
experiments in Chapter 2 examine mRNA and protein expression of Nrf2 and Nrf2-dependent
genes between male and female mice. The mouse closely resembles the type of response seen in
humans intoxicated with APAP in terms of susceptibility to hepatotoxicity and the sequence and
timing of events in hepatocyte injury and recovery. Additionally, the availability of genetically56

modified mice to explore mechanisms involved in APAP-induced hepatotoxicity, specifically with
respect to Nrf2, is further justification for using a mouse model for these studies.
It was demonstrated in Chapter 2 that Nrf2 is not responsible for the differential
susceptibility of male and female mice to APAP-induced hepatotoxicity. Lower Nrf2 mRNA and
protein expression was observed in livers of naïve WT female mice as well as overnight-fasted WT
female mice following vehicle- or APAP-treatment than in livers of male mice. Most notably, while
ALT activity was significantly elevated in both WT and Nrf2-null male mice following APAP
administration, no increases in ALT were observed in either genotype of female mice. Interestingly,
hepatic mRNA levels of Nqo1 and Mrp4 were consistently higher in naïve wild-type, overnightfasted wild-type, and Nrf2-null females than males.

This finding suggests that other factors

differentially expressed in male and female mice with greater expression in females than males may
regulate the transcription of these two genes, thereby resulting in greater resistance of female than
male mice to APAP-induced hepatotoxicity.

Future studies, however, are needed to better

understand the sex-dependent susceptibility of mice to APAP hepatotoxicity.
The experiments in Chapter 2 were designed to explore the sex differences in the role of
various gene targets involved in APAP-induced hepatotoxicity in mice. The results show that other
factors, rather than Nrf2 are responsible for the difference in susceptibility of male and female mice
to APAP-induced hepatotoxicity. The question remains then, if Nrf2 is not responsible for this sex
difference, what is? As mentioned previously, the basal and APAP-inducible mRNA expression
levels of Nqo1 and Mrp4 were consistently higher in female than male livers.

While the

transcriptional activity of these genes is known to be regulated by Nrf2, other transcriptional
regulators of these genes are known (Aleksunes, 2012). Future in silico studies examining the
promoter regions of these genes may aid in the identification of new regulatory sequences associated
with transcription factors differentially expressed between males and females.
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Further

understanding of the mechanism(s) contributing to the differential susceptibility of males and
females to APAP hepatotoxicity will allow for the identification of new drug targets, thereby
improving the development of new therapeutics targeting the treatment and prevention of druginduced liver injury.
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